Standout Papers
Immediate Impact
14 from Science/Nature 59 standout
Citing Papers
Refining the impact of genetic evidence on clinical success
2024 StandoutNature
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
2022 Standout
Works of Mark R. Fleisher being referenced
A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark R. Fleisher | 662 | 215 | 423 | 511 | 17 | 1.2k | |
| Cornelia Tillack | 846 | 324 | 683 | 479 | 33 | 1.5k | |
| Johannes Stallhofer | 627 | 176 | 566 | 357 | 28 | 1.2k | |
| Pavol Papay | 623 | 320 | 306 | 568 | 36 | 1.2k | |
| Deborah Woodworth | 1113 | 331 | 303 | 775 | 36 | 1.4k | |
| B. Tait | 438 | 224 | 300 | 155 | 34 | 1.1k | |
| Maria Roussomoustakaki | 555 | 556 | 214 | 417 | 27 | 1.1k | |
| Nathaniel Wisch | 751 | 309 | 166 | 503 | 24 | 1.2k | |
| C Cuvelier | 428 | 245 | 334 | 331 | 33 | 1.3k | |
| Natalia Pedersen | 789 | 366 | 177 | 592 | 14 | 1.2k | |
| Line Nielsen | 781 | 409 | 520 | 186 | 22 | 1.6k |
All Works
Loading papers...